FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073487130> ?p ?o ?g. }

• W2073487130 endingPage "2264" @default.
• W2073487130 startingPage "2256" @default.
• W2073487130 abstract "Long-term effects of a new selective estrogen receptor modulator (SERM) arzoxifene were examined in ovariectomized (OVX) rats. Arzoxifene was administered postoperatively (po) at 0.1 mg/kg per day or 0.5 mg/kg per day to 4-month-old rats, starting 1 week after OVX for 12 months. At study termination, body weights for arzoxifene groups were 16-17% lower than OVX control, which was caused by mainly reduced gain of fat mass. Longitudinal analysis of the proximal tibial metaphysis (PTM) by computed tomography (CT) at 0, 2, 4, 6,9, and 12 months showed that OVX induced a 22% reduction in bone mineral density (BMD) at 2 months, which narrowed to a 12% difference between sham-operated (sham) and OVX rats by 12 months. Both doses of arzoxifene prevented the OVX-induced decline in BMD. Histomorphometry of the PTM showed that arzoxifene prevented bone loss by reducing osteoclast number in OVX rats. Arzoxifene maintained bone formation indices at sham levels and preserved trabecular number above OVX controls. Micro-CT analysis of lumbar vertebrae showed similar preservation of BMD compared with OVX, which were not different from sham. Compression testing of the vertebra and three-point bending testing of femoral shaft showed that strength and toughness were higher for arzoxifene-treated animals compared with OVX animals. Arzoxifene reduced serum cholesterol by 44-59% compared with OVX. Uteri wet weight from arzoxifene animals was 38-40% of sham compared with OVX rats, which were 29% of sham. Histology of the uterine endometrium showed that cell heights from both doses of arzoxifene were not significantly different from OVX controls. In summary, treatment of OVX rats with arzoxifene for nearly one-half of a lifetime maintained beneficial effects on cholesterol and the skeleton. These data suggest that arzoxifene may be a useful therapeutic agent for osteoporosis in postmenopausal women." @default.
• W2073487130 created "2016-06-24" @default.
• W2073487130 creator A5006636591 @default.
• W2073487130 creator A5025166622 @default.
• W2073487130 creator A5032362159 @default.
• W2073487130 creator A5040096220 @default.
• W2073487130 creator A5041978225 @default.
• W2073487130 creator A5059175630 @default.
• W2073487130 creator A5060138777 @default.
• W2073487130 date "2002-12-01" @default.
• W2073487130 modified "2023-10-10" @default.
• W2073487130 title "Long-Term Dosing of Arzoxifene Lowers Cholesterol, Reduces Bone Turnover, and Preserves Bone Quality in Ovariectomized Rats" @default.
• W2073487130 cites W1479966533 @default.
• W2073487130 cites W1878298203 @default.
• W2073487130 cites W1963125733 @default.
• W2073487130 cites W1971624685 @default.
• W2073487130 cites W1975532319 @default.
• W2073487130 cites W1987144846 @default.
• W2073487130 cites W1994610843 @default.
• W2073487130 cites W1997883187 @default.
• W2073487130 cites W1998111806 @default.
• W2073487130 cites W1999076184 @default.
• W2073487130 cites W2008039212 @default.
• W2073487130 cites W2009144705 @default.
• W2073487130 cites W2035593552 @default.
• W2073487130 cites W2057754003 @default.
• W2073487130 cites W2058913891 @default.
• W2073487130 cites W2063031738 @default.
• W2073487130 cites W2063105575 @default.
• W2073487130 cites W2066727695 @default.
• W2073487130 cites W2067496513 @default.
• W2073487130 cites W2067718592 @default.
• W2073487130 cites W2068611177 @default.
• W2073487130 cites W2070619552 @default.
• W2073487130 cites W2073967278 @default.
• W2073487130 cites W2075499839 @default.
• W2073487130 cites W2075572846 @default.
• W2073487130 cites W2078303139 @default.
• W2073487130 cites W2079450135 @default.
• W2073487130 cites W2087378917 @default.
• W2073487130 cites W2093749501 @default.
• W2073487130 cites W2102477226 @default.
• W2073487130 cites W2112629831 @default.
• W2073487130 cites W2113264115 @default.
• W2073487130 cites W2114150652 @default.
• W2073487130 cites W2120955256 @default.
• W2073487130 cites W2133813353 @default.
• W2073487130 cites W2137208957 @default.
• W2073487130 cites W2139662795 @default.
• W2073487130 cites W2141653394 @default.
• W2073487130 cites W2156991169 @default.
• W2073487130 cites W2159837057 @default.
• W2073487130 cites W2400062840 @default.
• W2073487130 cites W2952009971 @default.
• W2073487130 cites W4234091781 @default.
• W2073487130 doi "https://doi.org/10.1359/jbmr.2002.17.12.2256" @default.
• W2073487130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12469920" @default.
• W2073487130 hasPublicationYear "2002" @default.
• W2073487130 type Work @default.
• W2073487130 sameAs 2073487130 @default.
• W2073487130 citedByCount "41" @default.
• W2073487130 countsByYear W20734871302012 @default.
• W2073487130 countsByYear W20734871302013 @default.
• W2073487130 countsByYear W20734871302020 @default.
• W2073487130 crossrefType "journal-article" @default.
• W2073487130 hasAuthorship W2073487130A5006636591 @default.
• W2073487130 hasAuthorship W2073487130A5025166622 @default.
• W2073487130 hasAuthorship W2073487130A5032362159 @default.
• W2073487130 hasAuthorship W2073487130A5040096220 @default.
• W2073487130 hasAuthorship W2073487130A5041978225 @default.
• W2073487130 hasAuthorship W2073487130A5059175630 @default.
• W2073487130 hasAuthorship W2073487130A5060138777 @default.
• W2073487130 hasBestOaLocation W20734871301 @default.
• W2073487130 hasConcept C126322002 @default.
• W2073487130 hasConcept C134018914 @default.
• W2073487130 hasConcept C170033053 @default.
• W2073487130 hasConcept C170493617 @default.
• W2073487130 hasConcept C2776033226 @default.
• W2073487130 hasConcept C2776541429 @default.
• W2073487130 hasConcept C2776886416 @default.
• W2073487130 hasConcept C2777164284 @default.
• W2073487130 hasConcept C2777425516 @default.
• W2073487130 hasConcept C2779329777 @default.
• W2073487130 hasConcept C71924100 @default.
• W2073487130 hasConcept C8264082 @default.
• W2073487130 hasConceptScore W2073487130C126322002 @default.
• W2073487130 hasConceptScore W2073487130C134018914 @default.
• W2073487130 hasConceptScore W2073487130C170033053 @default.
• W2073487130 hasConceptScore W2073487130C170493617 @default.
• W2073487130 hasConceptScore W2073487130C2776033226 @default.
• W2073487130 hasConceptScore W2073487130C2776541429 @default.
• W2073487130 hasConceptScore W2073487130C2776886416 @default.
• W2073487130 hasConceptScore W2073487130C2777164284 @default.
• W2073487130 hasConceptScore W2073487130C2777425516 @default.
• W2073487130 hasConceptScore W2073487130C2779329777 @default.
• W2073487130 hasConceptScore W2073487130C71924100 @default.
• W2073487130 hasConceptScore W2073487130C8264082 @default.
• W2073487130 hasIssue "12" @default.

• next